Renaissance Technologies’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.24M Sell
253,600
-87,400
-26% -$773K ﹤0.01% 2037
2025
Q1
$2.67M Sell
341,000
-46,800
-12% -$366K ﹤0.01% 1816
2024
Q4
$4.08M Buy
387,800
+366,300
+1,704% +$3.85M 0.01% 1580
2024
Q3
$282K Sell
21,500
-42,896
-67% -$563K ﹤0.01% 3004
2024
Q2
$905K Sell
64,396
-341,610
-84% -$4.8M ﹤0.01% 2379
2024
Q1
$6.86M Sell
406,006
-219,100
-35% -$3.7M 0.01% 1209
2023
Q4
$8.83M Sell
625,106
-113,800
-15% -$1.61M 0.01% 1011
2023
Q3
$7.61M Buy
738,906
+46,800
+7% +$482K 0.01% 1078
2023
Q2
$11.4M Sell
692,106
-127,648
-16% -$2.1M 0.02% 952
2023
Q1
$7.51M Buy
819,754
+133,948
+20% +$1.23M 0.01% 1248
2022
Q4
$4.91M Sell
685,806
-103,100
-13% -$738K 0.01% 1533
2022
Q3
$3.95M Sell
788,906
-65,100
-8% -$326K 0.01% 1583
2022
Q2
$2.08M Buy
854,006
+99,700
+13% +$243K ﹤0.01% 2155
2022
Q1
$5.15M Sell
754,306
-91,500
-11% -$625K 0.01% 1570
2021
Q4
$6.83M Sell
845,806
-7,500
-0.9% -$60.6K 0.01% 1307
2021
Q3
$8.36M Sell
853,306
-23,200
-3% -$227K 0.01% 1138
2021
Q2
$5.9M Sell
876,506
-52,800
-6% -$355K 0.01% 1526
2021
Q1
$8.4M Sell
929,306
-117,000
-11% -$1.06M 0.01% 1304
2020
Q4
$6.99M Sell
1,046,306
-190,377
-15% -$1.27M 0.01% 1385
2020
Q3
$6.23M Sell
1,236,683
-101,808
-8% -$513K 0.01% 1442
2020
Q2
$10.8M Buy
1,338,491
+432,685
+48% +$3.5M 0.01% 1171
2020
Q1
$7.19M Buy
905,806
+51,800
+6% +$411K 0.01% 1359
2019
Q4
$6.45M Buy
854,006
+32,000
+4% +$242K 0.01% 1708
2019
Q3
$3.42M Buy
822,006
+19,400
+2% +$80.7K ﹤0.01% 2004
2019
Q2
$2.32M Buy
802,606
+144,270
+22% +$417K ﹤0.01% 2252
2019
Q1
$948K Buy
658,336
+36,836
+6% +$53K ﹤0.01% 2689
2018
Q4
$1.6M Buy
621,500
+42,365
+7% +$109K ﹤0.01% 2347
2018
Q3
$2.54M Sell
579,135
-469,935
-45% -$2.06M ﹤0.01% 2164
2018
Q2
$6.43M Buy
1,049,070
+267,270
+34% +$1.64M 0.01% 1615
2018
Q1
$5.7M Sell
781,800
-362,800
-32% -$2.64M 0.01% 1731
2017
Q4
$9.39M Buy
1,144,600
+320,900
+39% +$2.63M 0.01% 1430
2017
Q3
$8.65M Buy
823,700
+125,427
+18% +$1.32M 0.01% 1424
2017
Q2
$7.7M Buy
698,273
+686,373
+5,768% +$7.57M 0.01% 1432
2017
Q1
$115K Buy
+11,900
New +$115K ﹤0.01% 3069